Drug intelligence / Profile preview

PtC10

Development stage
Preclinical
Lead developer
Northwest University
Modality
Small Molecules
Administration
Intravenous
01

Overview

PtC10 refers to two distinct experimental small molecule compounds primarily investigated for the treatment of hepatocellular carcinoma (HCC). The first is a **platinum(IV) prodrug** derived from oxaliplatin, modified with decyl (C10) axial ligands to enhance lipophilicity. This compound is designed for use in supramolecular drug delivery systems, such as pH-responsive vesicles formed with carboxylatopillar[6]arene (CP6A), which allow for targeted release in the acidic tumor microenvironment and synergistic combination with other agents like doxorubicin. The second compound, often stylized as **PTC10**, is a heterocyclic triad consisting of pyrazole, thiazole, and coumarin moieties. It functions as an inhibitor of the **Heat Shock Protein 90 (HSP90)** network, leading to G2 phase cell cycle arrest and the simultaneous suppression of oncogenic signaling pathways, including RAS/MAPK and PI3K-AKT. Both entities are currently in the preclinical stage of development.

Other names
PTC10PTC-10PTC 10oxaliplatin-type Pt(IV) prodrugpyrazole-thiazole-coumarin triad

Beyond the preview

Go deeper on PtC10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PtC10.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call